KATLYN HANSEN: Open Payments
NPI 1649693326 · MENASHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,352 in 48 payments from 9 companies in 2025. Trend: 2023 $1,323 · 2024 $1,600 · 2025 $1,352
Food & beverage: $1,341Education: $10
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 7 | $386 |
| Gilead Sciences, Inc. | 13 | $288 |
| Janssen Biotech, Inc. | 10 | $265 |
| ABBVIE INC. | 9 | $232 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| GENZYME CORPORATION | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| PFIZER INC. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $10 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, Livdelzi, DUPIXENT, SKYRIZI, ENTYVIO, XELJANZ.
Industry payments across WI — which companies pay providers there.
